Antimicrobials (including antifungals and antibiotics) and other types of drugs are used by livestock owners and veterinarians in the U.S. for control, treatment, or prevention of livestock diseases. Some of the countries outside North America and Europe can administer antimicrobials to augment the development rates of poultry, livestock, and other farmed animals, even though these drugs do not mandatorily have to be used by a veterinarian. The term animal antimicrobial or antibiotic is usually used for those agents who inhibit or kill the growth of microorganism in animals especially livestock.
Antibiotics are used for a variety of purposes in the husbandry of livestock, including therapeutic (treatment when ill), curing a batch of animals when a minimum of one among the group is diagnosed ill (metaphylaxis, it is similar to the method bacterial meningitis is managed in children), and prophylaxis or preventative treatment against a number of diseases. The employment of sub-therapeutic doses in water and/or animal feed to develop feed efficiency and encourage growth was eliminated altogether effective January 1, 2017, as per the new FDA Veterinary Feed Directive.
Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/522
The rising demand for livestock products, owing to increasing population of livestock throughout the world is likely to boost growth of the animal antimicrobials and antibiotics market. Moreover, the rising incidence of diseases in livestock is likely to aid in the expansion of this market. However, the use of in-feed enzymes and stringent regulations are limiting the growth of this market. Another factor boosting the overall growth of the market is the growing demand for animal proteins and the increasing trend of pet ownership. The growing incidences of animal disease epidemics, rising population of livestock and favorable economic conditions of emerging economies including China, Brazil, and India, are encouraging the growth of this market.
On the other hand, some factors including the augmented administration of in-feed enzymes, firm regulatory policies in the field and increased use of substitute medicines including prebiotics are likely to restrain the growth of the overall animal antimicrobials and antibiotics market during the forecast period.
High growth of livestock and increased consumption of milk and other food products will drive the overall animal antimicrobials and antibiotics market
The antimicrobial and antibiotic products have considerable benefits to the animal as well as to human food safety. Researchers have shown that a rise in the rate of animal illness invariably results into higher rate of illness among humans. Hence, livestock traders depend primarily on animal antibiotics to offer safe food. Another factor driving the market is the rising demand for meat, milk, and other animal food products. The profound usage of various types of meats and a variety of milk in the dairy products, especially in the western diet and the speedy adoption of these eating habits across the globe are expected to lead to a rise in demand for animal antimicrobials and antibiotics around the globe. These factors will fuel the growth of the animal antimicrobials and antibiotics market in the near future.
Get Access to TOC / Sample Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/522
On the basis of geography, North America held the largest share of the animal antibiotics and antimicrobials market. This dominance can be attributed to the developed animal healthcare market in this region. Other factors driving the market in this region are growing demand for animal-derivative food products, increasing expenditure on animal healthcare, rising animal population, and increase in awareness about the zoonotic diseases (disease transmitted from animals to humans). Nonetheless, the Asia-Pacific market is likely to grow at the maximum CAGR, due to rising animal population, growing demand for animal based food products, rise in awareness about animal welfare and animal health, especially in the emerging economies of China and India.
The key market players operating in the global animal antimicrobials and antibiotics market are Merck & Co., Inc., Zoetis, Inc., Bayer AG, Virbac, Eli Lilly Company, Boehringer Ingelheim GmbH, Vetoquinol S.A., Ceva Sante Animale, Dechra Pharmaceuticals PLC and Sanofi.